FarmPharma AB (publ) (“FarmPharma”), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the fourth recombinant cattle interferon, a component of FarmPharma’s product InterferOX, is manufactured in two versions: one in natural form and the other in abbreviated form. FarmPharma will choose which one to include in InterferOX based on their biological activity and stability.
“The development of antiviral agents with innovative mechanisms of action is becoming more and more relevant,” comments Igor Lokot, SO at FarmPharma. “We are very pleased that with the production of the fourth interferon, we have reached an important milestone in the development of InterferOX.” ”
The first interferons were manufactured earlier this year:
The first interferon
The second interferon
The third interferon
According to the plan, InterferOX will consist of 3-5 different types of interferon.